Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression

@article{Zhang2009ElectroconvulsiveTI,
  title={Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression},
  author={Xiaobin Zhang and Zhijun Zhang and Wei-wei Sha and Chunming Xie and Guangjun Xi and Hong-hui Zhou and Yumei Zhang},
  journal={Psychiatry Research},
  year={2009},
  volume={170},
  pages={273-275}
}
View on Elsevier
doi.org
59 Citations
Highly Influential Citations
1
Background Citations
18
Results Citations
6

Figures from this paper

59 Citations

A Preliminary Observation of Increased Glial Cell Line-Derived Neurotrophic Factor in Manic Switch due to Electroconvulsive Treatment in Depressive Patients
TLDR
The data suggest the role of GDNF in manic switch and the involvement of glial system in the pathogenesis of mood disorders.
Investigation of the effect of electroconvulsive treatment on serum glial cell line-derived neurotrophic factor levels in patients with schizophrenia and bipolar disorder
  • M. Akkuş
  • Psychology, Medicine
    Dusunen Adam:The Journal of Psychiatry and Neurological Sciences
  • 2022
TLDR
Investigation of the effect of electroconvulsive treatment on serum glial cell line-derived neurotrophic factor levels in patients with schizophrenia and bipolar disorder finds no change in serum levels of these neurotrophic factors.
Decreased glial cell line-derived neurotrophic factor levels in patients with depression: a meta-analytic study.
Circulating levels of GDNF in bipolar disorder
Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder
Circulating Glial-derived neurotrophic factor is reduced in late-life depression.
Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression.
Molecular Biomarkers of Electroconvulsive Therapy Effects and Clinical Response: Understanding the Present to Shape the Future
TLDR
An overview of the molecular studies on ECT, concerning its course and outcome prediction, including also animal studies on electroconvulsive seizures (ECS), an experimental analogue of ECT.
Association between serum levels of glial cell-line derived neurotrophic factor and attention deficits in schizophrenia
Glial Cell Line-Derived Neurotrophic Factor (GDNF) serum level in women with schizophrenia and depression, correlation with clinical and metabolic parameters
...
...

References

SHOWING 1-10 OF 32 REFERENCES
Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients
Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
TLDR
This is the first report of an increase in plasma BDNF concentration in patients receiving ECT, and preliminary results encourage further investigation of a neurotrophic mechanism for the antidepressant effect of ECT.
Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: A pilot study
Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients
Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders.
TLDR
It is suggested that lower GDNF levels might be involved in the pathophysiology of mood disorders, although this preliminary study has several limitations.
Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder
Altered expression of neurotrophic factors in patients with major depression.
Molecular and Cellular Actions of Chronic Electroconvulsive Seizures
TLDR
The hypothesis that ECS and antidepressant drugs, via regulation of neurotrophic factors, reverse the atrophy of stress-vulnerable neurons or protect these neurons from further damage is led to.
Antipsychotic drugs cause glial cell line-derived neurotrophic factor secretion from C6 glioma cells.
TLDR
This study suggests that stimulation of GDNF release from glial cells by antipsychotic drugs might underlie some of their neuroprotective properties in situ.
Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation.
...
...